Study: Stress, Anxiety, and Depression Can Increase Risk of Long COVID
while others don’t. Now, a new study has found a link between having certain mental health conditions and developing long COVID.and conducted by researchers at Harvard University, analyzed survey responses from nearly 55,000 people from April 2020 to November 2021. More than 3,000 of those people said they’d had COVID-19 and, of those, about 1,400 said they had developed long COVID.
Study co-author Siwen Wang, M.D., a postdoctoral research fellow at the Harvard T.H. Chan School of Public Health, says she and her research team wanted to study this because there are so many unknowns about long COVID. “It has been estimated that 8 to 23 million Americans may suffer from long-term COVID-19 symptoms,” she says. “Despite the high prevalence and daily life impairment associated with long COVID, long COVID is still poorly understood and few risk factors have been established.
Unfortunately, the study didn’t explore this—it simply established a link. Still, there are some theories.
Österreich Neuesten Nachrichten, Österreich Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Low Testosterone May Raise Risk of COVID HospitalizationMen with lower levels of testosterone were at increased risk for severe COVID-19, but androgen therapy appeared to provide protection, a new study found.
Weiterlesen »
Stress, anxiety or depression may increase long Covid risk: studyPeople who were experiencing psychological distress before getting Covid were more likely to have long-lasting symptoms than those who were not, according to new research.
Weiterlesen »
Using Hyperbaric Oxygen Treatment to treat long covidAn old treatment provides new relief for people suffering from debilitating conditions associated with long COVID-19.
Weiterlesen »
Commercializing COVID likely means more out-of-pocket costsAmericans will soon no longer have free access to government-funded COVID tests, treatments and vaccines. Those tools will move to the private sector — and likely be subject to some of the same issues found in the rest of the health care system.
Weiterlesen »